Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait — Stella

Home/Amputation/

View on ClinicalTrials.gov

Recruiting

Back to Amputation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Shirley Ryan AbilityLab, Chicago, Illinois

Key details

Sponsor

Shirley Ryan AbilityLab

Enrollment target

~20 participants

Started

May 2023

Primary completion

June 2028

Age range

18 Years – 95 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.